0001209191-22-020753.txt : 20220323 0001209191-22-020753.hdr.sgml : 20220323 20220323160018 ACCESSION NUMBER: 0001209191-22-020753 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220323 DATE AS OF CHANGE: 20220323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tray Thomas CENTRAL INDEX KEY: 0001912317 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 22763159 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-03-11 0 0000879169 INCYTE CORP INCY 0001912317 Tray Thomas 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 Principal Accounting Officer Common Stock 3238 D Common Stock 1399 I By Spouse Common Stock 554 D Common Stock 1886 D Common Stock 2870 D Common Stock 2322 D Common Stock 3649 D Incentive Stock Option (right to buy) 95.76 2026-01-06 Common Stock 1044 D Non-Qualified Stock Option (right to buy) 95.76 2026-01-06 Common Stock 1730 D Incentive Stock Option (right to buy) 95.76 2023-01-06 Common Stock 1005 D Non-Qualified Stock Option (right to buy) 95.76 2023-01-06 Common Stock 2436 D Non-Qualified Stock Option (right to buy) 83.83 2026-07-14 Common Stock 2639 D Incentive Stock Option (right to buy) 113.64 2027-01-16 Common Stock 879 D Non-Qualified Stock Option (right to buy) 113.64 2027-01-16 Common Stock 2642 D Non-Qualified Stock Option (right to buy) 113.64 2027-01-16 Common Stock 2639 D Non-Qualified Stock Option (right to buy) 128.34 2027-07-04 Common Stock 1677 D Incentive Stock Option (right to buy) 94.63 2028-01-22 Common Stock 1 D Non-Qualified Stock Option (right to buy) 94.63 2028-01-22 Common Stock 1676 D Incentive Stock Option (right to buy) 95.34 2028-01-23 Common Stock 1048 D Non-Qualified Stock Option (right to buy) 95.34 2028-01-23 Common Stock 5443 D Incentive Stock Option (right to buy) 68.62 2028-07-01 Common Stock 1 D Non-Qualified Stock Option (right to buy) 68.62 2028-07-01 Common Stock 5172 D Incentive Stock Option (right to buy) 72.27 2029-01-03 Common Stock 1383 D Non-Qualified Stock Option (right to buy) 72.27 2029-01-03 Common Stock 3349 D Non-Qualified Stock Option (right to buy) 72.27 2029-01-03 Common Stock 5173 D Non-Qualified Stock Option (right to buy) 85.01 2029-07-01 Common Stock 2289 D Non-Qualified Stock Option (right to buy) 80.50 2030-01-16 Common Stock 2290 D Incentive Stock Option (right to buy) 106.47 2030-07-01 Common Stock 324 D Non-Qualified Stock Option (right to buy) 106.47 2030-07-01 Common Stock 1896 D Incentive Stock Option (right to buy) 90.56 2031-01-14 Common Stock 324 D Non-Qualified Stock Option (right to buy) 90.56 2031-01-14 Common Stock 1896 D Incentive Stock Option (right to buy) 83.58 2031-07-01 Common Stock 815 D Non-Qualified Stock Option (right to buy) 83.58 2031-07-01 Common Stock 1808 D Incentive Stock Option (right to buy) 74.78 2032-01-18 Common Stock 383 D Non-Qualified Stock Option (right to buy) 74.78 2032-01-18 Common Stock 2240 D Represents restricted stock units ("RSUs") granted on July 2, 2018 that will vest fully on July 2, 2022. Represents restricted stock units ("RSUs") granted on July 2, 2019 that will vest 943 on July 2, 2022 and the remaining on July 2, 2023. Represents restricted stock units ("RSUs") granted on January 17, 2020 that will vest fully on January 17, 2024. Represents restricted stock units ("RSUs") granted on July 2, 2020 that will vest 774 on July 2, 2022, July 2, 2023 and July 2, 2024. Represents restricted stock units ("RSUs") granted on July 2, 2021 that will vest 912 on July 2, 2022, July 2, 2023, July 2, 2024 and the remaining will vest on July 2, 2025. As of March 11,2022, the award is fully vested and exercisable. Option granted on July 2, 2018 and becomes exercisable on July 2,2022. Options granted on July 2, 2018 and will vest monthly through July 2,2022. Options granted on January 4, 2019 and become exercisable in full on January 4, 2023. Options granted on January 4, 2019 and vest monthly through July 2,2022. Options granted on July 2, 2019 and vest monthly through July 2,2023. Options granted on January 17, 2020 and vest monthly through July 2,2023. Options granted on July 2, 2020 and will vest monthly starting January 2, 2024 through July 2, 2024. Options granted on July 2, 2020 and will vest monthly through December 2, 2023. Options granted on January 15, 2021 and will vest monthly starting January 2, 2024 through July 2, 2024 Options granted on January 15, 2021 and will vest monthly through December 2, 2023. Options granted on July 2, 2021 and will vest monthly starting January 2, 2024 through July 2, 2025. Options granted on July 2, 2021 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024. Options granted on January 19, 2022 and will vest monthly starting January 2, 2025 through July 2, 2025. Options granted on January 19, 2022 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024. /s/ Elizabeth Feeney 2022-03-23 EX-24 2 poa.txt POA DOCUMENT Power of Attorney Know all by these presents that the undersigned hereby constitutes and appoints each of Maria E. Pasquale, Christiana Stamoulis, and Elizabeth Feeney, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Incyte Corporation (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 11, 2022. /s/ Thomas R. Tray, Jr. Thomas R. Tray, Jr.